FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

768883004: Biphasic isophane insulin human (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3687359018 Biphasic isophane insulin human (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3687360011 Biphasic isophane insulin human en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Biphasic isophane insulin human This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Pancreatic hormone (disposition) false Inferred relationship Some
    Biphasic isophane insulin human Is a Human insulin false Inferred relationship Some
    Biphasic isophane insulin human Is a Insuline humaine recombinante isophane biphasique false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Insulin biphasic isophane human 10/90 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 10/90 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 20/80 100u/mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 20/80 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 20/80 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 30/70 100u/mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 30/70 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 30/70 100u/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 40/60 100u/mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 40/60 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 40/60 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 50/50 100u/mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 50/50 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 50/50 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 50/50 100u/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 15/85 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 25/75 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 25/75 100u/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Product containing biphasic isophane insulin human The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some 1
    Insulin biphasic isophane human 10/90 100u/mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 50/50 100u/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 15/85 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 15/85 100u/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Insulin biphasic isophane human 30/70 100u/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Product containing biphasic isophane insulin human in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some 1
    Insulin biphasic isophane human 25/75 100u/mL injection solution 3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Product containing only biphasic isophane insulin human (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some 1
    Product containing only biphasic isophane insulin human in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some 1

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start